Dr. Alejandro Madrigal, OBE FMedSci, MD PhD FRCP FRCPath DSc HonDSci

Officer of the Most Excellent Order of the British Empire
Past President of European Bone Marrow Transplantation
Former Director and Founder of the Antony Nolan Research Institute, UK.
Professor of Haematology, University College London, Cancer Institute
Distinguish Professor of the Technology Institute of Monterrey/Femsa
UCL Country Ambassador for México
Email: a.madrigal@ucl.ac.uk

Dr. Alejandro Madrigal began his medical studies at the Universidad Nacional Autónoma de México (UNAM) and continued his training at some of the world’s top universities. He is currently a Professor of Hematology at UCL, a Faculty of Excellence professor at the Tecnológico de Monterrey, and a Professor Emeritus of the National System of Researchers in Mexico. He was an Honorary Affiliated Physician at the Royal Free Hospital (UK) and UCL Cancer Institute.

He founded and served as the first scientific director of the Anthony Nolan Research Institute in London, which supports people with blood cancer or disorders. He has trained numerous doctors and scientists and has developed multiple Registers for Unrelated Stem Cell Donors (USCD) and cord blood collection centers. His research focuses on how to improve immunotherapy and stem cell transplantation to make cancer cell therapy more accessible, particularly for minorities. He is a Fellow of the Academy of Medical Sciences and a member of the Royal College of Physicians (UK) and holds honorary memberships in the National Academy of Medicine (Mexico) and the Mexican Academy of Sciences.

He has secured multiple grants and has funded students and researchers. He has published over 570 papers, with more than 17,000 citations in journals like Nature and The Lancet. In 2023, he received the Carlos Slim Health Award for Lifetime Achievement in Research for his work on health issues in Latin America. He also holds four honorary doctorates and was appointed an Officer of the Most Excellent Order of the British Empire (OBE) by Queen Elizabeth II in 2022.

Alejandro Madrigal joined Tecnológico de Monterrey as a FEMSA Distinguished Professor in Hematology and Cellular Therapy for the School of Medicine and Health Sciences.

Alejandro Madrigal joined Tecnológico de Monterrey as a FEMSA Distinguished Professor in Hematology and Cellular Therapy for the School of Medicine and Health Sciences.

Education and Training

• Postdoctoral studies, Harvard University
• Postdoctoral studies, Stanford University
• Doctoral studies, University College London (UCL)
• Medicine and specialty in Internal Medicine, Universidad Nacional Autónoma de México (UNAM)